Results 281 to 290 of about 36,390 (302)

Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

New England Journal of Medicine, 2014
Hector G Ortega, Mark C Liu, Ian D Pavord   +2 more
exaly  

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

Lancet, The, 2012
Ian D Pavord, Stephanie Korn, Peter Howarth   +2 more
exaly  

Non-eosinophilic cor ticosteroid unresponsive asthma

Lancet, The, 1999
Ian D Pavord, Chris E Brightling, G Woltmann   +2 more
exaly  

Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study

Clinical Therapeutics, 2019
Guy G Brusselle, Elisabeth H Bel, Stephanie Korn   +2 more
exaly  

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis

Journal of Allergy and Clinical Immunology, 2004
Peter Bradding, A J Wardlaw, Ian D Pavord   +2 more
exaly  

Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma

Journal of Allergy and Clinical Immunology, 2017
Steven W Yancey, Hector G Ortega, Oliver N Keene   +2 more
exaly  

Characteristics of eosinophilic and non-eosinophilic asthma during treatment with inhaled corticosteroids

Journal of Asthma, 2015
Yosuke Kimura, Ichiei Narita
exaly  

TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis

Journal of Allergy and Clinical Immunology, 2002
Christopher E Brightling, Surinder S Birring, Peter Bradding   +2 more
exaly  

Role of Eosinophils in Asthma, and the Relationship with Eosinophilic Sinusitis, Esophagitis and Asthma

Nihon Kikan Shokudoka Gakkai Kaiho, 2018
T. Iwanaga, Y. Tohda
openaire   +1 more source

Eosinophil protein in airway macrophages: A novel biomarker of eosinophilic inflammation in patients with asthma

Journal of Allergy and Clinical Immunology, 2010
Fay Hollins, Ruth Saunders, Salman Siddiqui   +2 more
exaly